CD19 car circRNA-LNP

This product is a lipid nanoparticle (LNP) formulation encapsulating a circular RNA (circRNA) encoding a CD19-targeting chimeric antigen receptor (CAR) . It is designed for research in CAR-T cell immunotherapy, enabling studies on RNA delivery efficiency, protein expression, and cell viability in both in vitro and in vivo experimental models.